ADPT Breaks Out! Cup & Handle Signals Up to 77% UpsideAdaptive Biotechnologies Corp.BATS:ADPTOmorfus```text #ADPT #long #active_management #investment_idea #stocks Today, we opened this long position in the premium channel, and in my opinion, the idea remains relevant. β Adaptive Biotechnologies #ADPT is an American biotechnology company specializing in immunogenomics. The company develops technologies for diagnostics, disease monitoring, and personalized treatment methods based on immune system analysis. π FUNDAMENTAL ANALYSIS π’ Adaptive Biotechnologies continues to actively develop its immune diagnostics segment and expand the commercial application of its immune sequencing platform. π’ The company collaborates with major pharmaceutical industry players, which provides additional revenue growth potential and supports long-term business development. π’ Financial results show steady revenue growth, while management continues to reduce operating expenses, gradually moving the company closer to profitability. π’ The development of personalized medicine and the integration of artificial intelligence technologies into healthcare make the immunogenomics sector one of the most promising areas for the coming years. π΄ The main risk is that the company is still unprofitable, so the stock remains highly volatile. π TECHNICAL ANALYSIS π LONG (Weekly Timeframe) βͺοΈ The chart has formed a classic bullish βCup and Handleβ pattern. βͺοΈ A strong breakout of key multi-year resistance has occurred, with the price consolidating above it. This is a strong signal for a continuation of the upward trend. βͺοΈ The price is confidently holding above the 50 EMA and continues moving toward the 200 EMA, opening room for further growth. βͺοΈ RSI is showing upward momentum and remains below the overbought zone, preserving potential for continued upside movement. βͺοΈ OsMA is in positive territory and continues to strengthen the bullish signal. βοΈ TRADE π― First target price: $26.58 π― Second target price: $35.10 π Upside potential β 77% πΌ Portfolio #active_management β οΈ The published ideas are not investment recommendations; they are only the private opinion of the blog author. ```